These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4675689)

  • 1. [Effect of fluoxymesterone (Halotestin) on progressive breast cancer].
    Yoshida Y; Miura S; Takeuchi S
    Horumon To Rinsho; 1972 Aug; 20(8):655-66. PubMed ID: 4675689
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effect of fluoxymesterone in the treatment of recurrent and progressive breast neoplasms].
    Takaya O
    Horumon To Rinsho; 1977 Dec; 25(12):1371-84. PubMed ID: 598046
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxymesterone as third line endocrine therapy for advanced breast cancer. A phase II trial of the Piedmont Oncology Association.
    Schifeling DJ; Jackson DV; Zekan PJ; Muss HB
    Am J Clin Oncol; 1992 Jun; 15(3):233-5. PubMed ID: 1590276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen-induced remissions after antiestrogen and hypophysectomy in stage IV breast cancer.
    Manni A; Arafah BM; Pearson OH
    Cancer; 1981 Dec; 48(11):2507-9. PubMed ID: 7296499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of adrenalectomy and androgen in disseminated mammary carcinoma.
    Dao TL; Nemoto T
    Surg Gynecol Obstet; 1965 Dec; 121(6):1257-62. PubMed ID: 4158865
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hormone treatment of breast cancer in the advanced phase].
    Demol R
    Brux Med; 1968 Oct; 48(10):665-9. PubMed ID: 5757971
    [No Abstract]   [Full Text] [Related]  

  • 7. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
    Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
    Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of the therapy combined with oophorectomy for the advanced breast cancer].
    Shinoda M; Oka T
    Gan No Rinsho; 1971; 17(9):670-5. PubMed ID: 5165861
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of sex hormones on peripheral immunity in patients with advanced breast cancer.
    Franks CR; Williams Y
    Clin Oncol; 1978 Mar; 4(1):19-24. PubMed ID: 639376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
    Murayama Y
    Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Calusterone (NSC-88536) in advanced breast cancer.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1976 Mar; 60(3):220-1. PubMed ID: 130973
    [No Abstract]   [Full Text] [Related]  

  • 12. Fluoxymesterone ("halotestin"): a new androgen.
    HUDSON B
    Med J Aust; 1959 Oct; 46(2)():468-70. PubMed ID: 14403738
    [No Abstract]   [Full Text] [Related]  

  • 13. Ataxia caused by fluoxymesterone therapy in breast cancer.
    Agrawal BL
    Arch Intern Med; 1981 Jun; 141(7):958-9. PubMed ID: 7235823
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced breast cancer with fluoxymesterone (halotestin).
    BECKETT VL; BRENNAN MJ
    Surg Gynecol Obstet; 1959 Aug; 109(2):235-9. PubMed ID: 13675999
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxymesterone (halotestin) in the treatment of advanced breast cancer.
    OLSON KB
    N Y State J Med; 1959 Jan; 59(2):248-52. PubMed ID: 13622979
    [No Abstract]   [Full Text] [Related]  

  • 16. The thermoprofile as an early indicator of breast cancer response to hormonal therapy.
    Stoll BA
    Cancer; 1971 Jun; 27(6):1379-83. PubMed ID: 4325984
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen and fluoxymesterone in advanced breast cancer: a controlled clinical trial.
    Westerberg H
    Cancer Treat Rep; 1980 Jan; 64(1):117-21. PubMed ID: 6991101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospective study of effect of fluoxymesterone on aplastic anemia (author's transl)].
    Hirota Y
    Rinsho Ketsueki; 1977 Nov; 18(11):1318-27. PubMed ID: 599662
    [No Abstract]   [Full Text] [Related]  

  • 19. 2alpha, 3alpha-epithio-5alpha-androstan-17beta-yl 1-methoxycyclopentyl ether in the treatment of advanced breast cancer: Japanese Cooperative Group of Hormonal Treatment for Breast Cancer.
    Cancer; 1978 Feb; 41(2):758-60. PubMed ID: 343913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical control of metastases in patients with advanced cancer of the breast.
    Sellwood RA; Burn I; Fotherby K
    Proc R Soc Med; 1974 Sep; 67(9):854-7. PubMed ID: 4610590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.